My bookmarksSign up free

Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

Delegated Regulation (EU) 2024/1401 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Delegated Regulation (EU) 2022/2104 is amended as follows: (1) Annex I is amended as follows: (a) table B is replaced by the table set out in Annex I to this Regulation; (b) its Appendix is deleted; (2) Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I ‘B.    Purity characteristics Category Fatty acid composition  ( 1 ) Total transoleic isomers (%) Total trans- linoleic + trans-linolenic isomers (%) Stigmasta- dienes (mg/kg)  ( 2 ) ΔΕCN42 2-glyceryl monopalmitate (%) Myristic (%) Linolenic (%) Arachidic (%) Eicosenoic (%) Behenic (%) Lignoceric (%) 1. Extra virgin olive oil ≤ 0,03 ≤ 1,00  ( 3 ) ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,05 ≤ 0,05 ≤ 0,05 ≤ |0,20 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,0 if total palmitic acid % > 14,00 % 2. Virgin olive oil ≤ 0,03 ≤ 1,00  ( 3 ) ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,05 ≤ 0,05 ≤ 0,05 ≤ |0,20 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,0 if total palmitic acid % > 14,00 % 3. Lampante olive oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,10 ≤ 0,10 ≤ 0,50 ≤ |0,30 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,1 if total palmitic acid % > 14,00 % 4. Refined olive oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,20 ≤ 0,30 — ≤ |0,30 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,1 if total palmitic acid% > 14,00 % 5. Olive oil composed of refined olive oil and virgin olive oils ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,20 ≤ 0,30 — ≤ |0,30 | ≤ 0,9 if total palmitic acid% ≤ 14,00 % ≤ 1,0 if total palmitic acid% > 14,00 % 6. Crude olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,20 ≤ 0,10 — ≤ |0,60 | ≤ 1,4 7. Refined olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,40 ≤ 0,35 — ≤ |0,50 | ≤ 1,4 8. Olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,40 ≤ 0,35 — ≤ |0,50 | ≤ 1,2 Table B continued Category Sterols composition Total sterols (mg/kg) Erythrodiol and uvaol (**) (%) Waxes (**) (mg/kg) Chole-sterol (%) Brassica-sterol (%) Campe-sterol(%) Stigmasterol (%) Apparent β–sito-sterol  ( 4 ) (%) Δ-7-stigma-stenol (%) 1. Extra virgin olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0  ( 5 ) < Camp. ≥ 93,0 ≤ 0,5  ( 6 ) ≥ 1 000 ≤ 4,5 C42 + C44 + C46 ≤ 150 2. Virgin olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0  ( 5 ) < Camp. ≥ 93,0 ≤ 0,5  ( 6 ) ≥ 1 000 ≤ 4,5 C42 + C44 + C46 ≤ 150 3. Lampante olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0 — ≥ 93,0 ≤ 0,5  ( 7 ) ≥ 1 000 ≤ 4,5  ( 8 ) C40 + C42 + C44 + C46 ≤ 300  ( 8 ) 4. Refined olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 9 ) ≥ 1 000 ≤ 4,5  ( 10 ) C40 + C42 + C44 + C46 ≤ 350 5. Olive oil composed of refined olive oil and virgin olive oils ≤ 0,5 ≤ 0,1 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 9 ) ≥ 1 000 ≤ 4,5 C40 + C42 + C44 + C46 ≤ 350 6. Crude olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 — ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 2 500 > 4,5  ( 12 ) C40 + C42 + C44 + C46 > 350  ( 12 ) 7. Refined olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 1 800 > 4,5 C40 + C42 + C44 + C46 > 350 8. Olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 1 600 > 4,5 C40 + C42 + C44 + C46 > 350 Notes: (a) The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4. (b) If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation. (c) For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category. (d) If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’ ( 1 )   Other fatty acids content (%): palmitic: 7,00-20,00; palmitoleic: 0,30-3,50; heptadecanoic: ≤ 0,40; heptadecenoic ≤ 0,60; stearic: 0,50-5,00; oleic: 55,00-85,00; linoleic: 2,50-21,00. ( 2 )   Total isomers which could (or could not) be separated by capillary column. ( 3 )   When the linolenic acid is more than 1,00 but less than or equal 1,40, the ratio apparent β-sitosterol/campesterol has to be greater than or equal to 24. ( 4 )   Apparent β-sitosterol: Δ-5,23-stigmastadienol+clerosterol+ β-sitosterol+sitostanol+ Δ-5-avenasterol+ Δ-5,24-stigmastadienol. ( 5 )   An extra virgin or virgin olive oil that exhibits 4,0 < campesterol % ≤ 4,5 is authentic provided that stigmasterol ≤ 1,4 %, Δ-7-stigmastenol ≤ 0,3 % and all other parameters lie within the limits fixed in this Regulation. ( 6 )   An extra virgin or virgin olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔECN42 ≤|0,10| and all other parameters lie within the limits fixed in this Regulation. ( 7 )   A lampante olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15|, stigmastadienes ≤ 0,30 mg/kg and all other parameters lie within the limits fixed in this Regulation. ( 8 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be lampante olive oil if the total aliphatic alcohol content is less than or equal to 350 mg/kg or if the erythrodiol and uvaol content is less than or equal to 3,5 %. ( 9 )   A refined olive oil or olive oil composed of refined olive oil and virgin olive oils that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15| and all other parameters lie within the limits fixed in this Regulation. ( 10 )   Oils with an erythrodiol + uvaol content of between 4,5 and 6 % must have an erythrodiol content of less than or equal to 75 mg/kg. ( 11 )   A crude olive-pomace oil or refined olive-pomace oil or olive-pomace oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that stigmasterol ≤ 1,4 %, ΔECN42 ≤ |0,40| and all other parameters lie within the limits fixed in this Regulation. ( 12 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be crude olive-pomace oil if the total aliphatic alcohol content is above 350 mg/kg and if the erythrodiol and uvaol content is greater than 3,5 %.

ANNEX IISupplementary provisions

ANNEX II ‘ANNEX III CORRELATION TABLE Implementing Regulation (EU) No 29/2012 Regulation (EEC) No 2568/91 This Regulation Implementing Regulation (EU) 2022/2105 — — Article 1, point (a)   — —   Article 1 — —   Article 2(2) Article 1(1)   Article 1, point (b), and Article 1(2)   Article 1(2)   Article 1, point (b)   Article 2, first paragraph   Article 4(1)   Article 2, second paragraph   Article 4(2)   Article 3, first paragraph   Article 6(1)   Article 3, second paragraph, points (a) to (d)   Article 6(2), points (a) to (d)   Article 4(1), first subparagraph   Article 8(1)   Article 4(1), second subparagraph   Article 8(2)   Article 4(1), third subparagraph   —   Article 4(2)   Article 8(3)   Article 4(3)   Article 8(4)   Article 4(4)   Article 8(5)   Article 4(5), first subparagraph   Article 8(6)   Article 4(5), second subparagraph   Article 8(7)   Article 4a   Article 7   Article 4b   Article 5   Article 5, first paragraph, points (a) to (d)   Article 10, points (a) to (d)   Article 5, first paragraph, point (e)   Article 11(1) and (2)   Article 5, second paragraph   —   Article 5a, first paragraph   Article 11(3)   Article 5a, second paragraph   Article 11(4)   Article 5a, third paragraph   Article 11(5)   Article 6(1), first subparagraph   Article 12(1)   Article 6(1), second subparagraph   Article 12(2)   Article 6(1), third subparagraph   Article 3(3)   Article 6(2), first subparagraph   Article 12(3)   Article 6(2), second subparagraph   Article 12(4)   Article 6(3)   Article 12(5)   — — Article 12(6)   Article 6(4)   —   Article 7     Article 5(2) Article 8(1)     Article 2(3) Article 8(2)     Article 4(3) Article 8(3)     Article 4(2) Article 8(4)     Article 4(3) Article 8a     Article 2(1) and Article 4(1) Article 9(1), first subparagraph     Article 13(1) Article 9(1), second subparagraph     Article 13(2) Article 9(1), third subparagraph     — Article 9(1), fourth subparagraph     — Article 9(1), fifth subparagraph     — Article 9(2),first subparagraph     Article 6(1) Article 9(2), second subparagraph, points (a), (b) and (c)     Article 6(2), points (a), (b) and (c) Article 9(2), third subparagraph   Article 9   —     Article 6(3) Article 10, first paragraph, introductory sentence     Article 14 Article 10, first paragraph, points (a) to (d), and second paragraph     — Article 10a     Article 14 Annex I   —   Annex II   —     Article 1(1) Article 2(1), points (a) and (b)     Article 1(2) Article 2(1), point (c)     Article 1(3) Article 2(1), point (d)     Article 1(4) Article 2(1), point (e)     Article 1(5) Article 2(1), point (f)     Article 1(6) Article 2(1), point (g)     Article 1(7) Article 2(1), point (h)   — — Article 2(2)   — — Article 3(1) and (2)     Article 2(1)   Article 7   Article 2(1), point (a)   Annex I, point 1   Article 2(1), point (b)   Annex I, point 2   Article 2(1), point (c)   —   Article 2(1), point (d)   —   Article 2(1), point (e)   Annex I, point 3   Article 2(1), point (f)   Annex I, point 4   Article 2(1), point (g)   Annex I, point 6   Article 2(1), point (h)   —   Article 2(1), point (i)   Annex I, point 5   Article 2(1), point (j)   Annex I, point 9   Article 2(1), point (k)   Annex I, point 10   Article 2(1), point (l)   Annex I, point 8   Article 2(1), point (m)   Annex I, point 7   Article 2(2), first subparagraph and part of point 9.4 of Annex XII   Article 10(1)   Article 2(2), second subparagraph   Article 11(1)   Article 2(2), third subparagraph   Article 11(2)   —   Article 11(3)   part of point 9.4 of Annex XII   Article 11(4)   Article 2(3), first subparagraph   Article 3(1)   Article 2(3), second subparagraph   Article 3(2)   Article 2(4), first subparagraph   Article 9(2)   Article 2(4), second subparagraph   Article 9(3)   Article 2(4), third subparagraph   Article 9(4)   Article 2(5)   Article 9(5)   Article 2a(1)   Article 3(1)   Article 2a(2)   Article 3(3)   Article 2a(3)   Article 3(4)   Article 2a(4), first subparagraph   Article 3(5)   Article 2a(4), second subparagraph   Article 3(2)   Article 2a(5)   Article 9(1)   Article 3, first paragraph   Article 13(1)   Article 3, second paragraph   Article 3(6)   Article 4(1), first subparagraph   Article 10(1)   Article 4(1), second subparagraph   Article 10(2)   Article 4(1), third subparagraph   Article 10(3)   Article 4(2)   Article 10(4)   Article 4(3)   -   Article 6(1)   Article 12(1)   Article 6(2)   Article 12(2)   Article 7   —   Article 7a, first subparagraph   Article 5(1)   Article 7a, second paragraph   Article 2(2)   Article 8(1)   —   Article 8(2)   Article 14   Annex I Annex I     Annex XII, point 3.3 Annex II     Annex Ia, except for point 2.1   Annex II   Annex Ia, point 2.1   Article 9(6)   Annex Ib   Annex III   Annex III   —   Annex IV   —   Annex VII   —   Annex IX   —   Annex X   —   Annex XI   —   Annex XII, except for point 3.3 and part of point 9.4   —   Annex XV   Annex IV   Annex XVI   —   Annex XVII   —   Annex XVIII   —   Annex XIX   —   Annex XX   —   Annex XXI   Annex V ’

Other acts of the same type
Commission Delegated Regulation (EU) 2022/1159 of 11 March 2022 supplementing Regulation (EU) 2019/2033 of the European Parliament and of the Council with regard to regulatory technical standards for public disclosure of investment policy by investment firms (Text with EEA relevance)Council Implementing Regulation (EU) 2022/408 of 10 March 2022 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Regulation (EU) 2022/410 of 10 March 2022 amending Regulation (EU) No 1321/2014 as regards the continuing airworthiness management in a single air carrier business grouping (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/413 of 10 March 2022 amending for the 330th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Implementing Regulation (EU) 2022/436 of 10 March 2022 entering a name in the register of protected designations of origin and protected geographical indications (‘Poivre de Penja’ (PGI))Commission Delegated Regulation (EU) 2022/930 of 10 March 2022 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council by specifying fees relating to the supervision by the European Securities Markets Authority of data reporting service providersCommission Delegated Regulation (EU) 2022/1011 of 10 March 2022 supplementing Regulation (EU) No 575/2013 of the European Parliament and of the Council with regard to regulatory technical standards specifying how to determine the indirect exposures to a client arising from derivatives and credit derivatives contracts where the contract was not directly entered into with the client but the underlying debt or equity instrument was issued by that client (Text with EEA relevance)Council Regulation (EU) 2022/394 of 9 March 2022 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCouncil Implementing Regulation (EU) 2022/396 of 9 March 2022 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Regulation (EU) 2022/398 of 9 March 2022 amending Regulation (EC) No 765/2006 concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against UkraineCommission Implementing Regulation (EU) 2022/402 of 9 March 2022 imposing a definitive anti-dumping duty on imports of certain aluminium foil originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2022/409 of 9 March 2022 amending for the 329th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisations

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next